GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » EV-to-EBITDA

Renata (DHA:RENATA) EV-to-EBITDA : 11.28 (As of Jul. 06, 2025)


View and export this data going back to . Start your Free Trial

What is Renata EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Renata's enterprise value is BDT72,066 Mil. Renata's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was BDT6,389 Mil. Therefore, Renata's EV-to-EBITDA for today is 11.28.

The historical rank and industry rank for Renata's EV-to-EBITDA or its related term are showing as below:

DHA:RENATA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.12   Med: 17.48   Max: 96.08
Current: 11.28

During the past 13 years, the highest EV-to-EBITDA of Renata was 96.08. The lowest was 11.12. And the median was 17.48.

DHA:RENATA's EV-to-EBITDA is ranked better than
59.32% of 730 companies
in the Drug Manufacturers industry
Industry Median: 14.19 vs DHA:RENATA: 11.28

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-07-06), Renata's stock price is BDT486.50. Renata's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was BDT24.528. Therefore, Renata's PE Ratio (TTM) for today is 19.83.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Renata EV-to-EBITDA Historical Data

The historical data trend for Renata's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renata EV-to-EBITDA Chart

Renata Annual Data
Trend Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.55 15.99 19.52 34.47 15.23

Renata Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.07 15.23 14.74 14.04 11.53

Competitive Comparison of Renata's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Renata's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renata's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renata's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Renata's EV-to-EBITDA falls into.


;
;

Renata EV-to-EBITDA Calculation

Renata's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=72065.965/6388.696
=11.28

Renata's current Enterprise Value is BDT72,066 Mil.
Renata's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT6,389 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renata  (DHA:RENATA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Renata's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=486.50/24.528
=19.83

Renata's share price for today is BDT486.50.
Renata's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT24.528.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Renata EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Renata's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Renata Business Description

Traded in Other Exchanges
N/A
Address
Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Renata PLC is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.

Renata Headlines

No Headlines